KLSE (MYR): TMCLIFE (0101)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.645
Today's Change
-0.005 (0.77%)
Day's Change
0.645 - 0.65
Trading Volume
271,300
Market Cap
1,124 Million
NOSH
1,742 Million
Latest Quarter
31-Mar-2024 [#3]
Announcement Date
23-May-2024
Next Quarter
30-Jun-2024
Est. Ann. Date
22-Aug-2024
Est. Ann. Due Date
29-Aug-2024
QoQ | YoY
-31.42% | -30.32%
Revenue | NP to SH
356,946.000 | 52,869.000
RPS | P/RPS
20.49 Cent | 3.15
EPS | P/E | EY
3.04 Cent | 21.25 | 4.71%
DPS | DY | Payout %
0.84 Cent | 1.30% | 27.68%
NAPS | P/NAPS
0.51 | 1.26
QoQ | YoY
-7.58% | 6.85%
NP Margin | ROE
14.81% | 5.95%
F.Y. | Ann. Date
31-Mar-2024 | 23-May-2024
Latest Audited Result
30-Jun-2023
Announcement Date
04-Oct-2023
Next Audited Result
30-Jun-2024
Est. Ann. Date
04-Oct-2024
Est. Ann. Due Date
27-Dec-2024
Revenue | NP to SH
311,443.000 | 39,257.000
RPS | P/RPS
17.88 Cent | 3.61
EPS | P/E | EY
2.25 Cent | 28.62 | 3.49%
DPS | DY | Payout %
0.84 Cent | 1.30% | 37.27%
NAPS | P/NAPS
0.49 | 1.32
YoY
-5.15%
NP Margin | ROE
12.60% | 4.60%
F.Y. | Ann. Date
30-Jun-2023 | 22-Aug-2023
Revenue | NP to SH
363,058.666 | 52,832.000
RPS | P/RPS
20.84 Cent | 3.09
EPS | P/E | EY
3.03 Cent | 21.27 | 4.70%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-10.95% | 52.33%
NP Margin | ROE
14.55% | 5.95%
F.Y. | Ann. Date
31-Mar-2024 | 23-May-2024
Date | Financial Result | Financial Ratio | Per Share Item | Performance | Valuation (End of Quarter) | Valuation (Ann. Date) | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
F.Y. | Ann. Date | Quarter | # | Revenue | PBT | NP | NP to SH | Div | Net Worth | Div Payout % | NP Margin | ROE | NOSH | RPS | Adj. RPS | EPS | Adj. EPS | DPS | Adj. DPS | NAPS | Adj. NAPS | QoQ | YoY | EOQ Date | EOQ Price | EOQ P/RPS | EOQ P/EPS | EOQ P/NAPS | EOQ EY | EOQ DY | ANN Date | ANN Price | ANN P/RPS | ANN P/EPS | ANN P/NAPS | ANN EY | ANN DY |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
results will be better and better only....with new wing opening, more bed capacity, more revenue and profit
2022-02-10 13:09
New wing started to contribute to the financial result. As time goes, significant improvement will show very soon.
2022-08-24 07:14
Less men more share then? Contrarian approach? Perhaps another takeover target.
2023-12-13 23:10
Bot enough, start to promote.
https://klse.i3investor.com/web/blog/detail/sinchew_company_story/2024-01-01-story-h-211423465
2024-01-01 22:51
Alpha IVF listing with RM1.5 billion valuation soon,i think TMC was very much undervalued at current price.
2024-03-02 01:13
Beside IVF business which is recovering strongly,TMC also owned Thomson Hospital Kota Damansara,a premium hospital with 336 operating bed currently and maximum capacity of 554 bed when fully utilized the new wing by 2026.
2024-03-02 01:22
my personal opinion, TMC should worth around RM2 .0 to 2.4 billion based on FY2024 EV/Ebitda of 18-20x,the target valuation consider quite conservative given the rapid capacity expansion and high growth potential in next 5 year.
2024-03-02 01:31
Price did not react much to the 2nd letter to the suspended CEO. It looks good.
2 months ago
With the existing 314 medical beds, the hospital segment generated RM 82 million in a quarter. TMC would increase quantity of bed to 394 (in Kota Damansara) by Jun 2024. Expect revenue up by RM 20 million per quarter for extra 80 beds.
2 months ago
Potential of leap in revenue growth until 2027 with the medical beds capacity 554 units. TMC has added 80 medical bed in 2024 and follow by 80 units each for year 2025 and 2026.
2 months ago
According tot the annual report, it will only commence construction after RTS starts running
1 month ago
展望下半年,目前马股可谓利好环绕,获经济展望强稳、企业获利复苏、资金回流等因素加持,交投料保持活络,可望延续上半年强势。选股方面,笔者相对看好消费、建筑及科技股,整体料在利好加持下表现可期。
配合半年检讨,笔者决定对神通科技(SCOMNET,0001,创业板医疗保健组)和优宾机构(EUPE,6815,主机板产业组)进行套利,同时对TMC生命科学(TMCLIFE,0101,主机板医疗保健组)停损。
3 weeks ago
Myeye
If confident them invest regularly for long term. ~.~
2021-11-26 09:58